SurModics Inc (NASDAQ:SRDX)
During the Trading Day
| 26.16 |  +0.03 / +0.11% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 26.16 |  0.00 / 0.00% |
Volume: 1.2K |
Latest SRDX News | Press Releases
| 1 Reason SurModics May Be Headed for a Slowdown May 16 / MotleyFool.com |
Today’s Trading
| Previous close | 26.13 |
| Today’s open | 25.88 |
| Day’s range | 25.88 - 26.24 |
| Volume | 53,486 |
| Average volume (3 months) | 82,758 |
| Market cap | $378.9M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +52.46% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -23.39% |
| P/E ratio | 30.1 |
| Price/Sales | 6.74 |
| Price/Book | 4.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SMASymmetry Medical Inc | +0.19 | +1.86% |
| ANGOAngioDynamics Inc | -0.02 | -0.19% |
| CERSCerus Corp | -0.12 | -2.29% |
| UNISUnilife Corp | +0.06 | +1.57% |
Data as of 4:03pm ET, 05/23/2013
Financials
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.22 |
| Annual revenue (last year) | $51.9M |
| Annual profit (last year) | $11.3M |
| Net profit margin | 19.51% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Gary R. Maharaj, MBA |
Chief Financial Officer & Vice President Andrew D. C. LaFrence, CPA |
Corporate headquarters Eden Prairie, Minnesota |
Forecasts
